ORALINK Trademark

Trademark Overview

On Wednesday, August 28, 2024, a trademark application was filed for ORALINK with the United States Patent and Trademark Office. The USPTO has given the ORALINK trademark a serial number of 98721681. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, March 4, 2025. This trademark is owned by D&D Pharmatech, Inc.. The ORALINK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services
oralink

General Information

Serial Number98721681
Word MarkORALINK
Filing DateWednesday, August 28, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameD&D Pharmatech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13486
KR

Trademark Events

Event DateEvent Description
Wednesday, August 28, 2024NEW APPLICATION ENTERED
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 4, 2025ASSIGNED TO EXAMINER

Related Keywords

oralink pharmaceutical services development research products drug